Stimulus‐Detonated Biomimetic “Nanobomb” with Controlled Release of HSP90 Inhibitor to Disrupt Mitochondrial Function for Synergistic Gas and Photothermal Therapy
Authors:
- 26 May 2023
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (26) , e2300945
Abstract
Photothermal therapy (PTT) is considered a promising treatment for tumors; however, its efficacy is restricted by heat shock proteins (HSPs). Herein, a stimuli‐responsive theranostic nanoplatform (M/D@P/E‐P) is designed for synergistic gas therapy and PTT. This nanoplatform is fabricated by a load of manganese carbonyl (MnCO, CO donor) in dendritic mesoporous silicon (DMS), followed by the coating with polydopamine (PDA) and loading of epigallocatechin gallate (EGCG, HSP90 inhibitor). Upon near‐infrared (NIR) irradiation, the photothermal effect of PDA can kill tumor cells and allow for the controlled drug release of MnCO and EGCG. Moreover, the acidity and H 2 O 2 ‐rich tumor microenvironment enable the decomposition of the released MnCO, accompanied by the production of CO. CO‐initiated gas therapy can realize to disrupt the mitochondrial function, which will accelerate cell apoptosis and down‐regulate HSP90 expression by decreasing intracellular ATP. The combination of EGCG and MnCO can significantly minimize the thermo‐resistance of tumors and improve PTT sensitivity. In addition, the released Mn 2+ enables T 1 ‐weighted magnetic imaging of tumors. The therapeutic efficacy of the nanoplatform is methodically appraised and validated both in vitro and in vivo. Taken together, this study affords a prime paradigm for applying this strategy for enhanced PTT via mitochondrial dysfunction.Keywords
Funding Information
- National Natural Science Foundation of China (U19A2006)
- National Natural Science Foundation of China (12132004)
- National Natural Science Foundation of China (32171395)
This publication has 31 references indexed in Scilit:
- Graphene oxide / BaHoF5 / PEG nanocomposite for dual-modal imaging and heat shock protein inhibitor-sensitized tumor photothermal therapyCarbon, 2020
- Gas-Mediated Cancer Bioimaging and TherapyACS Nano, 2019
- Rhodiola crenulata attenuates apoptosis and mitochondrial energy metabolism disorder in rats with hypobaric hypoxia-induced brain injury by regulating the HIF-1α/microRNA 210/ISCU1/2(COX10) signaling pathwayJournal of Ethnopharmacology, 2019
- Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced NanomedicineACS Nano, 2019
- Carbon monoxide (CO)-Strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia inductionBiomaterials, 2019
- Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal ImagingACS Nano, 2019
- Biocompatible Heat-Shock Protein Inhibitor-Delivered Flowerlike Short-Wave Infrared Nanoprobe for Mild Temperature-Driven Highly Efficient Tumor AblationACS Applied Materials & Interfaces, 2019
- Heat Shock Protein (HSP) Drug Discovery and Development: Targeting Heat Shock Proteins in DiseaseCurrent Topics in Medicinal Chemistry, 2016
- Hsp90 Inhibitors Promote p53-Dependent Apoptosis through PUMA and BaxMolecular Cancer Therapeutics, 2013
- Heat shock protein inhibitors and vaccines as new agents in cancer treatmentExpert Opinion on Investigational Drugs, 2009